10.05.2019
- UK drugmaker Vectura has won a patent infringement lawsuit against UK pharma giant GlaxoSmithKline (GSK) in the US and been granted $89.7 million in damages. The lawsuit filed by...
18.01.2018
- GlaxoSmithKline (GSK), the UK’s largest drugmaker in terms of sales, is rumored to be preparing a bid for compatriot Vectura, an inhaled airways disease-focused player. The two...
18.03.2016
- UK drug maker Vectura is buying fellow biotechnology firm Skyepharma in a deal worth around £441 million ($637 million). The merger will create an industry leading specialist in...
29.07.2013
- Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro...
